Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Hims & Hers is now offering generic semaglutide through its platform to eligible customers in Canada, marking the company’s first international generic GLP-1 offering. The personalized treatment plans, which include medication access plus ongoing care support and lifestyle guidance, start at $149 CAD per month, significantly below the typical cost of branded versions like Ozempic. Generic semaglutide is authorized by Health Canada for Type 2 diabetes and may be prescribed off‑label for weight management by licensed Canadian providers. Hims & Hers does not currently offer treatment services for Type 2 diabetes in Canada and instead focuses on weight‑management programs delivered through its telehealth platform with local Canadian medical providers.